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Abstract 1 
 2 
Background  Inorganic nitrate from the oxidation of endogenously synthesized nitric oxide 3 
or consumed in the diet can be reduced to nitric oxide via a complex entero-salivary 4 
circulation pathway.  The relationship between total nitrate exposure by measured urinary 5 
nitrate excretion and blood pressure in a large population sample has not been assessed 6 
previously.   7 
Methods  Twenty four hour urinary nitrate excretion was measured by spectrophotometry in 8 
the 919 participants from the InChianti cohort at baseline and blood pressure measured with a 9 
mercury sphygmomanometer.   10 
Results   After adjusting for  age and sex only, Diastolic blood pressure was 1.94 mm Hg 11 
lower in subjects with ≥2mmol urinary nitrate excretion compared with those excreting 12 
<1mmol nitrate in 24 hours: Systolic blood pressure was 3.41mm Hg (95%CI -3.48 to -0.39) 13 
lower in subjects for the same comparison.  14 
Effect sizes in fully adjusted models (for age, sex, potassium intake, use of anti-hypertensive 15 
medications, diabetes, HS-CRP, or current smoking status) were marginally larger: systolic 16 
blood pressure in the ≥2mmol urinary nitrate excretion group was 3.87 (CI -7.06 to -0.69) 17 
mm HG lower than in the comparison <1 mmol excretion group.   18 
Conclusions  Modest differences in total nitrate exposure are associated with reductions in 19 
blood pressure which are at least equivalent to those seen from substantial (100mmol) 20 
reductions in sodium intake. 21 
 22 
Key Words: Nitrate, diet, hypertension 23 
 24 
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 25 
Introduction 26 
 27 
The continuous generation of nitric oxide (NO) from the oxidation of L-arginine by nitric 28 
oxide synthase (NOS) in the vascular endothelium plays a significant role in the control of 29 
vascular tone1.  The vasodilatory action of NO is terminated by its rapid oxidation to nitrite 30 
and nitrate2,3.  It has been shown that there is an entero-salivary pathway whereby nitrate can 31 
be reduced to nitrite by commensal bacteria on the mammalian tongue4, with the nitrite 32 
produced swallowed in the saliva.  This nitrite is absorbed into the circulation and can have a 33 
blood pressure lowering effect either directly or by further reduction to NO5.  In addition to 34 
the NOS pathway nitrate may also be obtained from the diet, with green leafy vegetables and 35 
beetroot particularly rich in inorganic nitrate6. 36 
 37 
A typical western diet sees the consumption of 1-2mmol inorganic nitrate per day, 38 
predominantly from vegetables7,8.  Humans produce approximately 1 mmol nitrate per day 39 
from the oxidation of endogenously synthesized NO9.  It had been shown in hypertension and 40 
other associated conditions that endogenous synthesis of NO is diminished10.   Trials of 41 
inorganic nitrate supplementation using beetroot juice5, a range of nitrate rich vegetables11, 42 
and pharmacological sodium or potassium nitrate12 have shown a range of blood pressure 43 
effects from substantial reductions in systolic5,12-14 and diastolic pressures11, reductions in 44 
blood pressure variability15 to no effect16,17.  There has been considerable heterogeneity 45 
between studies in terms of populations studied and dose and duration of nitrate provided18. 46 
 47 
Beyond a possible blood pressure lowering effect inorganic nitrate supplementation may have 48 
multiple other beneficial effects including improvements in endothelial function5, reductions 49 
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in the oxygen cost of exercise13, improvements in cognitive function19, protection against 50 
ischaemia reperfusion injury20 along with potentially positive effects on metabolism21,22.   51 
 52 
Synthesis studies and some dietary intervention studies rely on the restriction of inorganic 53 
nitrate intake10,17.  There have been no large scale population studies of the effect of total 54 
nitrate exposure, from both endogenous and dietary sources, on blood pressure.  We 55 
examined the association between 24 hour urinary nitrate excretion, as a marker of both 56 
endogenous and dietary nitrate exposure, and blood pressure in the InChianti study.   57 
 58 
Methods 59 
 60 
Study population and design 61 
We obtained baseline 24 hour urine samples from the InCHIANTI study, a prospective 62 
population-based study of older people, conducted by the Laboratory of Clinical 63 
Epidemiology of the Italian National Institute of Research and Care on Aging 64 
(INRCA), Florence, Italy.  Ethical approval was granted by The INRCA Ethical Committee. 65 
 66 
The InChianti study aimed to recruit the older residents in two towns of the Chianti area 67 
(Greve in Chianti and Bagno a Ripoli, Tuscany, Italy) plus younger controls, and achieved a 68 
91.6% response rate at baseline. Data collection commenced in September 1998 and 69 
completed in March 2000. Sampling procedure and data collection method has been 70 
published previously23. 71 
 72 
 73 
 74 
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Measures 75 
Resting supine blood pressure was measured twice in both arms using a mercury 76 
sphygmomanometer.  For the purposes of the present analyses we used the data from the limb 77 
with the highest recorded value.  The mean of 2 values from this arm was used.   78 
 79 
Total nitrate exposure was determined by measurement of 24 hour urinary nitrate excretion.  80 
Mean daily nitrate excretion was 1.33 mmol, with a standard deviation SD=1.1 and a range of 81 
0 to 8.5 mmol. Subjects with 24 hour urine volume less than 400 ml (n=6) were excluded 82 
from analysis as such low volumes are unlikely to represent complete collections. 83 
Urinary nitrate concentration was measured using the  spectrophotometric plate method 84 
described by Miranda et al24.  We have validated this method in urine samples against the 85 
gold standard ozone chemiluminescence method we have used previously (see on line data 86 
supplement). Each sample/standard (100 µl) was added to a 96 well plate, followed by 100 µl 87 
VCl3 (0.1 M VCl3 in 1M HCl) and 100 µl Greiss reagent (sulphanilamide, 2% w/v in 5% 88 
HCl, and N-(1-naphthyl)ethylenediamine dihydrochloride (NEDD), 0.1 % w/v in water, 89 
mixed in equal volumes immediately before use) and incubated at 37 OC for 30 min. 90 
Absorbance was read using a plate reader at 540 nm. The VCl3 reduces the nitrate in the 91 
sample to nitrite which then forms a coloured chromogen upon reaction with the Greiss 92 
reagent.  Thus the assay does not differentiate between nitrite and nitrate.  As the 93 
concentration of nitrate is approximately 1000 times that of nitrite in urine25,26, a ratio that at 94 
the very least persists following nitrate supplementation26, we have reported the results as 95 
urinary nitrate concentration. 96 
Urine samples were diluted 1 in 10 so that measurements were within the linear range of the 97 
standard curve (1 – 500 µM). A urine blank was required for each sample, as samples varied 98 
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in their turbidity. Any samples where the duplicates varied by >10% were repeated and the 99 
coefficient of variation was 8.5 %. A small proportion (3%) of samples had poor replication 100 
of duplicates even on repeat duplicate analysis. These samples were filtered using 0.22 µm 101 
syringe filters before analysis, and this additional step provided good duplicates with < 10% 102 
variation. 103 
Sample and Statistical analysis 104 
The selection of subjects and variables for statistical modelling was based on our Directed 105 
Acyclic Graph of hypothesised causal influences linking nitrate excretion and measured 106 
blood pressure (see appendix A)27. Nitrate levels were measured in 24 hour urine samples 107 
from 1188 respondents. Data on 6 patients were excluded due to urine volumes less than 108 
400ml, 215 for definite or probable congestive heart failure or missing data and 48 for a 109 
creatinine clearance (Cockcroft-Gault) <30 or missing data. The sample available for analysis 110 
was 421 men and 498 women (n=919 total) aged 21 to 95 years old. 111 
Regression models were adjusted initially for age-group and gender, and then additionally for 112 
estimated daily potassium intake from a diet diary, high sensitivity C-Reactive protein, 113 
diabetes, current smoking, activity level in the last year and highest educational attainment.  114 
Further adjustment was made for 24 hour urinary sodium excretion.  Models were also 115 
adjusted for antihypertensive medication, with separate terms for ACE inhibitors, diuretics, 116 
beta-blockers, peripheral vasodilators and other antihypertensives.  117 
Analysis was carried out in Stata 13 using robust linear regression models.  118 
 119 
 120 
 121 
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Results 122 
 123 
A total of 919 subjects were included in the analysis. Forty eight percent (n=441) of the 124 
sample had 24 hour nitrate excretion of <1 mmol, 33% (307) had 1 to <2 mmol and 19% ≥2 125 
mmol (table 1). Overall 73.3% of the sample was aged 65 and over, and 45.8% were male. 126 
25.6% were receiving at least one antihypertensive and 10.7% had definite or probable 127 
diabetes. There were significant differences in the age distribution by increasing category of 128 
nitrate excretion, with fewer of the older sample in the higher nitrate categories.  129 
 130 
The mean diastolic blood pressure was 82.8 (SD 9.5) and mean systolic 143.1 (standard 131 
deviation 21.1).  132 
 133 
In simple age sex adjusted models only (Table 2), Diastolic blood pressure was 1.94 mm Hg 134 
lower in subjects with ≥2mmol urinary nitrate excretion compared with those excreting 135 
<1mmol nitrate in 24 hours: Systolic blood pressure was 3.41mm Hg (95%CI -3.48 to -0.39) 136 
lower in subjects for the same comparison. Differences in blood pressures with the nitrate 1 137 
to <2 mmol excretion group were intermediate, and statistically significant for diastolic blood 138 
pressure only.   A tend estimate (per nitrate group change) in mean systolic blood pressure 139 
was significant (ceoff -1.82 SE 0.79, p=0.022).  140 
 141 
Regression coefficients for fully adjusted models (for age, sex, potassium intake, the use of 142 
anti-hypertensive medications, diabetes, HS-CRP, or current smoking status) were marginally 143 
larger: for example, systolic blood pressures in the ≥2mmol urinary nitrate excretion group 144 
was 3.87 (CI -7.06 to -0.69) mm HG lower than in the comparison <1 mmol excretion group. 145 
Adjusting the model for 24 hour urinary sodium excretion did affect the outcome. 146 
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 147 
As nitrate excretion may diminish with declining GFR,  an additional sensitivity analysis 148 
adjusting for renal function (Cockcroft-Gault estimate) was performed.  The association 149 
between higher urinary nitrate excretion (≥2 mmol per day) and mean systolic blood pressure 150 
remained significant (coefficient -4.40 SE 1.58, p=0.005). 151 
 152 
 153 
Discussion 154 
 155 
The primary finding that systolic and diastolic blood pressure are 3.87 and 2.28 mm Hg lower 156 
in individuals with the highest nitrate exposure compared with the lowest provides further 157 
evidence to support strategies targeted at increasing NO bioavailabilty.   158 
 159 
In an age and sex adjusted model, the InterSalt Cooperative Study Group found 3.5 mm Hg 160 
systolic and 1.5 mm Hg diastolic reductions in blood pressure when sodium intake was 161 
lowered by 100mmol/day28.  After adjustment for potassium excretion, BMI, and alcohol 162 
intake reduces these estimates were more modest with reductions of to 2.2 mm Hg systolic 163 
and 0.1 mm Hg diastolic.  In an additional sensitivity analysis of our data, adjusting for BMI 164 
(as a continuous variable) and daily alcohol intake (grouped), the association between higher 165 
urinary nitrates (≥2 mmol per day) and mean systolic blood pressure remained significant 166 
(coefficient -4.18 SE 1.57 p=0.008).If we assume a causal relationship, the very modest 167 
increment in nitrate intake required to achieve a urinary nitrate excretion may have at least 168 
equivalent effects on blood pressure to the more far reaching dietary changes which would be 169 
required to reduced sodium intake by 100mmol/day.  To put these changes in to context, a 170 
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single serving of 80mg of a high nitrate vegetable such as rocket or spinach can provide 2-3 171 
mmol in organic nitrate29.   172 
 173 
It has previously been shown that 60-65% of inorganic nitrate is excreted in the urine within 174 
24 hours in young healthy subjects30.  It is not known how the remainder is excreted nor if 175 
these rates and proportions change with increasing age or in the setting of various 176 
pathological conditions.  It is however likely, that in the population studied, 24 hour urinary 177 
nitrate excretion represents a fair reflection of overall nitrate exposure. 178 
 179 
This study cannot determine whether endogenous synthesis or dietary sources of nitrate made 180 
the greatest overall contribution to overall nitrate exposure.  In Tessari et al’s study basal 181 
NOx synthesis rates were not different between young, elderly, hypertensive or 182 
hypercholesteroleamic subjects with a maximum rate of 0.75 ± 0.4 mmol/day31.  In earlier 183 
work by Forte et all, under conditions of low exogenous nitrate, 24 h urinary nitrate excretion 184 
was lower in hypertensive patients than in controls, mean 0.450 [SEM 37] vs 0.760 mmoles 185 
[77] /day10.  It is likely based on estimated synthesis rates from these previously reported 186 
studies that those in the highest excretion category in the current study will have had the 187 
highest dietary exposure regardless of endogenous synthesis rates.   188 
 189 
It would have been of interest to look for a relationship between dietary nitrate intake and 190 
urinary nitrate excretion. However the food item questionnaire was not designed to assess 191 
this.  Consequently it does not cover sufficient high nitrate vegetables to permit such an 192 
analysis.  Diets rich in fruit and vegetables are high in potassium.  We adjusted the model for 193 
potassium intake in order to indirectly account for the effect a high fruit and vegetable intake 194 
per se, with no impact on the outcome.    195 
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 196 
Many of the previously published intervention studies demonstrating a blood pressure 197 
lowering effect from inorganic nitrate supplementation have looked at young healthy 198 
subjects5,13.  There are some data to support a blood pressure lowering effect in older 199 
adults14,32 however this is not consistent, particularly in groups with pathology17,33,34.  The 200 
age range of the InChianti cohort begins at 65 and include individuals of greater than 90 years 201 
of age.  It includes a large number of subjects with typical age-related co-morbidity. 202 
 203 
Previous intervention studies have suggested a threshold of around 4mmol/day from dietary 204 
sources could lead to blood pressure lowering effects12.  The present data suggests if there is 205 
a threshold effect, it may be at lower levels of dietary consumption.  What is not clear is if a 206 
dose response exists above or below any such threshold.  A meta-analysis of intervention 207 
studies using beetroot juice (dose range 5.1 to 45 mmol/day) or nitrate salts (dose range 2.5 to 208 
24 mmol/day)found a -4.4 mm Hg (95% CI: -5.9, 2.8); P < 0.001, reduction in systolic blood 209 
pressure and a non-significant trend towards lower diastolic BP -1.1 mm Hg (95% CI:-2.2, 210 
0.1); P = 0.0618.  The findings in the present study are in keeping with the observed results 211 
derived from a range of nitrate doses.  212 
 213 
Limitations – 214 
In evaluating these results we note that sample studied is predominantly older and from the 215 
Chianti region of Italy, and generalisability to other groups needs to be established.  It has 216 
previously been shown  by Hill et al that urinary nitrate excretion varies significantly across 217 
geographical regions, likely reflecting differences in the dominant dietary habits of a given 218 
region35.   219 
 220 
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The analysis is observational and cross-sectional, and therefore directions of causation cannot 221 
be established: longer term randomised trials will be needed to confirm the results reported. 222 
Many of the patients in the sample were on antihypertensive medications, and although 223 
numbers of medications at baseline were not associated with nitrate excretion category, some 224 
biasing effect may remain from medication. Despite these limitations, our use of a relatively 225 
large population based sample with 24 hour urine collections plus a structured approach to 226 
model exclusions and adjustments is likely to have provided robust results.  227 
 228 
InChianti was primarily designed a tool to investigate health and mobility in the elderly.  It 229 
was not designed with blood pressure studies in mind and while the methods for measuring 230 
blood pressure is not identical to recommendations from recognised hypertension societies 231 
we feel that the measures we have selected closely reflect guidelines for clinical practice36.          232 
 233 
This association of lower blood pressure with relatively modest increases in urinary nitrate 234 
excretion, which could easily be achieved with minor dietary modification, provides further 235 
support for interventions targeted at increasing dietary nitrate exposure at population level.  236 
Further work is needed to assess the impact of measured urinary nitrate exposure on health 237 
outcomes. 238 
 239 
A robust, high throughput, assay for measurement of inorganic nitrate in biological fluids 240 
represents a major advance in the field.  The previous ozone chemiluminescence method is 241 
time consuming and laborious.  The spectrophotometric plate method developed by Miranda 242 
et al and validated by us for use in urine for the current study offers the prospect of large 243 
scale epidemiological studies in the field of inorganic nitrate research and the realistic 244 
possibility of an assay that could be used in clinical practice.  245 
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 246 
The degree of difference in blood pressure seen between the lowest to highest nitrate 247 
exposures in the InChianti cohort would likely be translated to substantial reductions in 248 
morbidity and mortality at the population level.  Though the difference in blood pressure was 249 
relatively modest it was observed at modest differences in total nitrate exposure.  Crucially 250 
the 1-2mmoles nitrate that would be required to elevate exposure from the lowest to the 251 
highest group can be obtained from small portions of green leafy vegetables or beetroot.  252 
Furthermore there are no known adverse effects of such an approach.  253 
 254 
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 496 
Table 1: characteristics of the sample (number, %) by category of 24 497 
hour nitrate excretion   498 
   
24 hour nitrate excretion 
(mmol) 
    
 
<1 
 
1 to <2 
 
≥2  
 
Total 
 
p-value 
 
Number % Number % Number % Number % 
 
Sample total  441 
 
307 
 
171 
 
919 
  
          
Age group  
        
<0.001 
21 to 44 24 5.4 56 18.2 45 26.3 125 13.6 
 
45 to 64 42 9.5 51 16.6 27 15.8 120 13.1 
 
65 to 74 215 48.8 147 47.9 74 43.3 436 47.4 
 
75 to 84 128 29.0 40 13.0 20 11.7 188 20.5 
 
85+ 32 7.3 13 4.2 5 2.9 50 5.4 
 
          
Male 185 42.0 154 50.2 82 48.0 421 45.8 0.070 
          Number of antihypertensive 
medications  
      
0.647 
None 321 72.8 234 76.2 129 75.4 684 74.4 
 
one  99 22.4 63 20.5 35 20.5 197 21.4 
 
Two plus 21 4.8 10 3.3 7 4.1 37 4.0 
 
          
Diabetes 
        
0.653 
Definite 47 10.7 26 8.5 16 9.4 89 9.7 
 
Probably  4 0.9 2 0.7 3 1.8 9 1.0 
 
          Diastolic blood pressure, mmHg 
(means, sd)  
       
 
84.3 9.1 81.9 9.5 80.5 9.9 82.8 9.5 
 Systolic blood pressure , mmHg 
(means, sd) 
       
 
147.1 20.3 141.0 21.2 136.6 20.5 143.1 21.1 
  499 
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Table 2: Age sex and fully adjusted linear regression coefficients for systolic and diastolic 520 
blood pressure (measured in mm Hg) by 24 hour nitrate excretion groups (compared to 521 
<1 mmol)  522 
 523 
 
Age sex adjusted only 
  
Fully adjusted models  
 Nitrate 
excretion 
mmol/day* Coefficient 95% CI 
p-
value 
 
Coefficient 95% CI 
p-
value 
Diastolic  
       <1 
       
1 to <2 -1.35 (-2.69 to -0.01) 0.049 
 
-1.51 (-2.87 to -0.16) 0.029 
≥2 -1.94 (-3.48 to -0.39) 0.014 
 
-2.28 (-3.83 to -0.72) 0.004 
        
Systolic 
       
<1 
       
1 to <2 -1.29 (-4.09 to 1.52) 0.368 
 
-1.4 (-4.27 to 1.47) 0.338 
≥2 -3.41 (-6.56 to -0.26) 0.034 
 
-3.87 (-7.06 to -0.69) 0.017 
Note: *Sample numbers by nitrate excretion (mmol/day): <1 n=441,  1 to <2 n=307,  ≥2 n=171             524 
 525 
